Reduced-intensity allogeneic stem cell transplantation for children with neuroblastoma who failed tandem autologous stem cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduced-intensity allogeneic stem cell transplantation for children with neuroblastoma who failed tandem autologous stem cell transplantation

Published:2011-06-16 Issue:4 Volume:57 Page:660-665
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Sung Ki Woong,Park Jun Eun,Chueh Hee Won,Lee Soo Hyun,Yoo Keon Hee,Koo Hong Hoe,Kim Ju Youn,Cho Eun Joo

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference34 articles.

1. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid;Matthay;N Engl J Med,1999

2. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: A randomised controlled trial;Berthold;Lancet Oncol,2005

3. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: Long-term survival update;George;J Clin Oncol,2006

4. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma;Grupp;J Clin Oncol,2000

5. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: Results of the Chicago Pilot II Study;Kletzel;J Clin Oncol,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response‐adapted consolidation therapy strategy for patients with metastatic high‐risk neuroblastoma: Results of the SMC NB‐2014 study;Pediatric Blood & Cancer;2024-07-04

2. Stem Cell Therapy for High-Risk Neuroblastoma: Stem Cell Transplantation and Targeting Cancer Stem Cells;Comprehensive Hematology and Stem Cell Research;2024

3. Immunotherapy for neuroblastoma by hematopoietic cell transplantation and post-transplant immunomodulation;Critical Reviews in Oncology/Hematology;2023-05

4. Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine Neuroblastoma;Frontiers in Immunology;2021-08-19

5. High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience;Annals of Nuclear Medicine;2020-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3